Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of inhaled oxytocin (GR121619) in healthy female volunteers for postpartum hemorrhage. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Oxytocin (GR121619) inhaled (oxytocin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Postpartum Hemorrhage | Phase 1 | Status: COMPLETED